Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spontaneous Mutations Play a Key Role in Congenital Heart Disease

Published: Monday, May 13, 2013
Last Updated: Monday, May 13, 2013
Bookmark and Share
New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.

Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease.

Many of these defects can be repaired though surgery, but researchers don’t understand what causes them or how to prevent them.

Although genetic factors contribute to congenital heart disease, many children born with heart defects have healthy parents and siblings, suggesting that new mutations that arise spontaneously-known as de novo mutations-might contribute to the disease.

“Until recently, we simply didn’t have the technology to test for this possibility,” says Howard Hughes Medical Institute (HHMI) investigator~Richard Lifton.

Lifton, who is at Yale School of Medicine, together with Christine Seidman, an HHMI investigator at Brigham and Women’s Hospital and colleagues at Columbia, Mt. Sinai, and the University of Pennsylvania, collaborated to study congenital heart disease through the National Heart Lung and Blood Institute’s Pediatric Cardiac Genomics Consortium.

Using robust sequencing technologies developed in recent years, the researchers compared the protein-coding regions of the genomes of children with and without congenital heart disease and their parents, and found that new mutations could explain about 10 percent of severe cases.

The results demonstrated that mutations in several hundred different genes contribute to this trait in different patients, but were concentrated in a pathway that regulates key developmental genes.

These genes affect the epigenome, a system of chemical tags that modifies gene expression.

For the current study, the investigators began with 362 families consisting of two healthy parents with no family history of heart problems and a child with severe congenital heart disease.

By comparing genomes within families, they could pinpoint mutations that were present in each child’s DNA, but not in his or her parents. The team also studied 264 healthy families to compare de novo mutations in the genomes of healthy children.

The team focused their gene-mutation search on the exome - the small fraction of each person’s genome that encodes proteins, where disease-causing mutations are most likely to occur.

Children with and without congenital heart disease had about the same number of de novo mutations - on average, slightly less than one protein-altering mutation each.

However, the locations of those mutations were markedly different in the two groups. “The mutations in patients with congenital heart disease were found much more frequently in genes that are highly expressed in the developing heart,” Seidman says.

The differences became more dramatic when the researchers zeroed in on mutations most likely to impair protein function, such as those that would cause a protein to be cut short.

Children with severe congenital heart disease were 7.5 times more likely than healthy children to have a damaging mutation in genes expressed in the developing heart.

The researchers found mutations in a variety of genes, but one cellular pathway was markedly enriched in the children with heart defects. That pathway helps regulate gene activity by affecting how DNA is packaged inside cells.

The body’s DNA is wrapped around proteins called histones, and chemical tags called methyl groups are added to histones to control which genes are turned on and off.

In children with congenital heart disease, the team found an excess of mutations in genes that affect histone methylation at two sites that are known to regulate key developmental genes.

Overall, the researchers found that de novo mutations contribute to 10 percent of cases of severe congenital heart disease. Roughly a third of this contribution is from the histone-methylation pathway, Lifton says. He also notes that a mutation in just one copy of a gene in this pathway was enough to markedly increase the risk of a heart defect.

Direct sequencing of protein-coding regions of the human genomes to hunt down de novo mutations has only been applied to one other common congenital disease-autism. In that analysis, Lifton and his colleagues at Yale, as well as HHMI investigator Evan Eichler and colleagues at University of Washington, found mutations in some of the same genes mutated in congenital heart disease, and the same histone modification pathway appears to play a major role in autism as well, raising the possibility that this pathway may be perturbed in a variety of congenital disorders, Lifton says.

Even if the disease can’t be prevented, identifying the mutations responsible for severe heart defects might help physicians better care for children with congenital heart disease.

“After we repair the hearts of these children, some children do great and some do poorly,” Seidman says.

Researchers have long suspected that this might be due to differences in the underlying causes of the disease. Understanding those variations might help doctors improve outcomes for their patients.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A New View of Transcription Initiation
Reading the human genome.
Monday, March 04, 2013
Search for Epigenetic Decoder in Brain Cells Leads Scientists to Rett Syndrome
New analysis suggests that MeCP2 recognizes 5hmC in the brain and facilitates activation of the genes.
Monday, December 31, 2012
HHMI’s Robert Lefkowitz Awarded 2012 Nobel Prize in Chemistry
Robert Lefkowitz and Brian K. Kobilka are the recipients of the 2012 Nobel Prize in Chemistry for studies of G-protein coupled receptors.
Thursday, October 11, 2012
Autism Gene Screen Highlights Protein Network for Howard Hughes Medical Institute Scientists
Over the past decade, scientists have added many gene mutations to the list of potential risk factors for autism spectrum disorders -- but researchers still lack a definitive explanation of autism’s cause.
Thursday, April 05, 2012
Protein-Folding Game Taps Power of Worldwide Audience to Solve Difficult Puzzles
Extended efforts could pay off in the design of new proteins that help fight disease, sequester carbon, or clean up the environment.
Monday, August 09, 2010
Mutations in Different Cells Cooperate to Set the Stage for Cancer
HHMI researchers have shown that distinct cancer-causing mutations in neighboring cells can cooperate to produce tumors.
Friday, January 15, 2010
Scientists Identify New Genetic Culprit for Intellectual Disability
HHMI researchers identified a genetic mutation that plays a role in intellectual disability.
Monday, December 14, 2009
Sticklebacks Hone Defenses through Small DNA Deletions
A single genetic adjustment is enough to help a small fish make a big change, HHMI researchers find.
Friday, December 11, 2009
Studies Begin to Shape New Image of DNA
Researchers to develop a new picture of DNA that shows the molecule’s more dynamic side, which is capable of morphing into a large number of complex shapes.
Monday, November 09, 2009
Diagnosis Emerges from Complete Sequencing of Patient's Genes
HHMI researchers have identified a gene mutation that was responsible for the patient’s disease, but had not been suspected based on clinical observations.
Wednesday, October 28, 2009
Diagnosis Emerges from Complete Sequencing of Patient's Genes
Howard researchers used high-throughput DNA sequencing technology to identify a gene mutation that was responsible for the patient’s disease.
Tuesday, October 20, 2009
A Proliferation of Amyloid Arrangements
New research shows that variations in each fibril-forming protein’s arrangements may represent a protein-based system of inheritance between cells that parallels the genetic code.
Tuesday, August 25, 2009
Study Pinpoints Genetic Drivers of Lung Cancer’s Spread
Howard Hughes Medical Institute investigator find that lung cancer uses to seed deadly new tumors in the brain, bone marrow, and other organs.
Friday, July 03, 2009
New Strategy Reveals Targets for MicroRNA Gene Regulation
Researchers use HITS-CLIP technique to map the binding points of scores of different microRNAs throughout a genome in living mouse or human tissue.
Friday, June 19, 2009
New Studies Reveal Broad, Hidden Network that Lets Tumors Thrive
Howard researchers identify potential new drug targets for cancers long deemed “untouchable” due to the type of genetic mutation they contain.
Monday, June 01, 2009
Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Grant to Fund Million Peaks Project
The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA).
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!